1. Rosenstrauch D, Poglajen G, Zidar N, Gregoric ID. Stem cell therapy for ischemic heart failure. Texas Heart Institute Journal. 2005; 32(3): 339-347.
2. Wang J-S, Shum-Tim D, Galipeau J, Chedrawy E, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. The Journal of thoracic and cardiovascular surgery 2000; 120(5): 999-1006.
3. Gepstein L, Ding C, Rehemedula D, Wilson EE, et al. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells. 2010; 28(12): 2151-2161.
4. Barbash IM, Chouraqui P, Baron J, Feinberg MS, et al. Systemic delivery of bone marrow–derived mesenchymal stem cells to the infarcted myocardium feasibility, cell migration, and body distribution. Circulation 2003; 108(7): 863-868.
5. McBurney MW, Rogers BJ. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Developmental biology. 1982; 89: 503-508.
6. Zwi-Dantsis L, Huber I, Habib M, et al. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. European Heart Journal . 2012; 10: 1093.
7. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of the National Academy of Sciences. 1981; 78 (12): 7634-7638..
8. Motamedi R, Azadbakht M, Fathi F, Amini A, et al. In Vitro Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Cardiomyocyte- like Cells. Yakhteh. 2010; 12(3): 387-394.
9. Cohen ED, Tian Y, Morrisey EE. Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development. 2008; 135(5): 789-798.
10. Makino S, Fukuda K, Miyoshi S, Konishi F, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. Journal of Clinical Investigation 1999; 103(5): 697-705.
11. Shim WS, Jiang S, Wong P, Tan J, et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochemical and biophysical research communications 2004; 324(2): 481-488.
12. Oh H, Bradfute SB, Gallardo TD, Nakamura T, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences 2003; 100: 12313-12318.
13. Wang HS, Hung SC, Peng ST, Huang CC, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22(7): 1330-1337.
14. Hamidabadi HG, Pasbakhsh P, Amidi F, Soleimani M, et al. Functional Concentrations of BMP4 on Differentiation of Mouse Embryonic Stem Cells to Primordial Germ Cells. IJFS. 2011; 5: 104-109.
15. Martin‐Rendon E, Sweeney D, Lu F, Girdlestone J, et al. 5‐Azacytidine‐treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox sanguinis. 2008; 95: 137-148.
16. Dambrot C, Passier R, Atsma D, Mummery C. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochem J. 2011; 434(1): 25-35.
17. Baharvand H, Azarnia M, Parivar K, Ashtiani SK. The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J mol and cell cardiol. 2005; 38(3): 495-503.
18. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigation 2001; 108: 407-414.
19. Huber I, Itzhaki I, Caspi O, Arbel G, et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. The FASEB Journal 2007; 21: 2551-2563.
20. Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells the role of 5-azacytidine. Interactive cardiovascular and thoracic surgery. 2007; 6(5): 593-597.
21. Balana B, Nicoletti C, Zahanich I, Graf EM, et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Research. 2006; 16: 949-960.
22. Marvin MJ, Di Rocco G, Gardiner A, Bush SM, et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes & development. 2001; 15: 316-327.
23. Tzahor E, Lassar AB. Wnt signals from the neural tube block ectopic cardiogenesis. Genes & development. 2001; 15: 255-260.
24. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. Journal of Clinical Investigation. 1996; 98(1): 216-224.
25. Segev H, Kenyagin‐Karsenti D, Fishman B, Gerecht‐Nir S, et al. Molecular analysis of cardiomyocytes derived from human embryonic stem cells. Development, growth & differentiation 2005; 47(5): 295-306.
26. Xu W, Zhang X, Qian H, Zhu W, et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Experimental Biology and Medicine. 2004; 229: 623-631.
27. Cai C-L, Liang X, Shi Y, Chu P-H, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Developmental cell. 2003; 5: 877-889.
28. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circulation research. 2002; 91(6): 501-508.
29. Snir M, Kehat I, Gepstein A, Coleman R, et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 2003; 285(6): H2355-H2363.